FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/066425 [Registered on: 29/04/2024] Trial Registered Prospectively
Last Modified On: 25/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing the effects of two different doses of Dexmedetomidine and observing for which dose has a moresignificant decrease in the agitation resulting from Sevoflurane usage in Paediatric patients posted for lower Abdominal Surgeries 
Scientific Title of Study   Comparison of two different doses of Dexmedetomidine in attenuation of Sevoflurane associated Emergence Agitation in paediatric patients posted for lower abdominal surgeries A Hospital based Randomised Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tejasvini Kalathuru 
Designation  Junior Resident 
Affiliation  JAWAHARLAL NEHRU MEDICAL COLLEGE, BELAGAVI 
Address  Department of Anaesthesiology Jawaharlal Nehru Medical College Belagavi

Belgaum
KARNATAKA
590010
India 
Phone  9962728749  
Fax    
Email  tejureddy.kalathuru@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mahantesh S Mudankanagoudar 
Designation  Professor 
Affiliation  KLE Dr. Prabhakar Kore Hospital and MRC 
Address  Department of Anaesthesiology Jawaharlal Nehru Medical College Belagavi

Belgaum
KARNATAKA
590010
India 
Phone  7829164500  
Fax    
Email  drmontygoudar@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mahantesh S Mudakangoudar 
Designation  Professor 
Affiliation  KLE Dr. Prabhakar Kore Hospital and MRC 
Address  DEpartment of Anaesthesiology Jawaharlal Nehru Medical College Belagavi

Belgaum
KARNATAKA
590010
India 
Phone  7829164500  
Fax    
Email  drmontygoudar@yahoo.co.in  
 
Source of Monetary or Material Support  
Department of Anaesthesiology Jawaharlal Nehru Medical College Belagavi 
 
Primary Sponsor  
Name  DrTejasvini Kalathuru 
Address  Department of Anaesthesiology Jawaharlal Nehru Medical College Belagavi 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrTejasvini Kalathuru  KLE Dr. Prabhakar Kore Hospital  Department of Anaesthesiology Jawaharlal Nehru Medical College Belagavi
Belgaum
KARNATAKA 
9962728749

tejureddy.kalathuru@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
JNMC INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Administration of dexmedetomidine  comparison of two different doses of dexmedetomidine (0.3mcg/kg and 0.5mcg/kg) administered via intravenous route as an infusion over 10 mins to look for attenuation of sevoflurane associated emergence agitation in pediatric patients undergoing lower abdominal surgeries under general anaesthesia using laryngeal mask airway and caudal anaesthesia. 
Comparator Agent  administration of dexmedetomidine  comparison of two different doses of dexmedetomidine (0.3mcg/kg and 0.5mcg/kg) administered via intravenous route as an infusion over 10 mins to look for attenuation of sevoflurane associated emergence agitation in pediatric patients undergoing lower abdominal surgeries under general anaesthesia using laryngeal mask airway and caudal anaesthesia. 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  ASA physical status I and II.
Age between 2 to 10 years.
Patients undergoing lower abdominal surgeries
Operation time less than or equal to 1 hour. 
 
ExclusionCriteria 
Details  risk of aspiration
known difficult airway
Patients with Upper respiratory tract infections
congenital malformations involving respiratory tract
History of epilepsy
Patients with cardiac, renal or liver diseases
Patients with allergy to the study drug
cervical spine disease 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare effects of 0.3 mcg/kg and 0.5mcg/kg of dexmedetomidine in attenuation
of emergence agitation in paediatric patient maintained on Sevoflurane, undergoing
lower abdominal surgeries. 
after surgery
10 mins
20 mins
30 mins
40 mins
50 mins
1 hour
every 1 hour until 24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Hemodynamic parameter assessment for 24 hours after administration of study drug.  every 1 hour until 24 hours post surgery 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   06/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   its a novel study comparing the effects of two different doses of dexmedetomidine on the emergence agitation with the use of inhalational agent such as sevoflurane in pediatric patients undergoing lower abdominal surgeries performed under general anesthesia with a laryngeal mask airway and caudal anesthesia. it shall provide valuable insight on the usage of the optimal dexmedetomidine dose to avoid or reduce the incidence of sevoflurane associated emergence agitation in pediatric patients. 
Close